Skip to main content
. 2024 Jan 26;15:1239496. doi: 10.3389/fimmu.2024.1239496

Figure 6.

Figure 6

Correlation between hub Genes and SES-CD, and efficacy differences of infliximab in Crohn’s disease patients. (A–E) Correlation of 5 hub genes with clinical SES-CD. (F) Response of Crohn’s disease patients to infliximab.